Paracetamol-Tramadol and Paracetamol-caffeine Versus Placebo in the Emergency Discharge Treatment of Renal Colic — RC  

Renal Colic Clinical Trial

Official title: Paracetamol-Tramadol and Paracetamol-caffeine Versus Placebo in the Emergency Discharge Treatment of Renal Colic

Status Not yet recruiting

Clinical Trial Summary

This is a prospective, randomized, single-blind study. Patients included in the study after successful treatment of the acute attack were randomized upon discharge from the Emergency Department into three groups: oral paracetamol-tramadol group, oral paracetamol-caffeine group and oral placebo group.

Clinical Trial Description

This is a prospective, randomized, single-blind study. Patients included in the study after successful treatment of the acute attack were randomized upon discharge from the Emergency Department into three groups: oral paracetamol-tramadol group, oral paracetamol-caffeine group and oral placebo group. Different parameters are collected on a standard form prepared for all cases of renal colic included in our study. This sheet essentially contains: Temperature, systolic and diastolic blood pressure, heart rate, pain intensity assessed by VAS, abdominal tenderness as well as the existence of Giardano signs. Additional examinations were not systematically carried out for all patients: AUSP, ECBU, renal ultrasound, creatinemia and blood sugar. Their realization depended on the clinical context. The use of imaging was done following the indications specified in the text of the consensus of the French Society of Emergency Medicine (updated in 2008) ;

Related Conditions & MeSH terms

• Colic
• Emergencies
• Renal Colic

• NCT number: NCT06345716
• Study type: Interventional
• Source: University of Monastir
• Contact: Khaoula Bel Haj Ali
• Phone: 99792724
• Email: belhajalikhaoula@yahoo.fr
• Status: Not yet recruiting
• Phase: Phase 2
• Start date: April 10, 2024
• Completion date: November 30, 2025